Blood cell changes in giant cell arteritis
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study looks at changes in blood cells that may happen in giant cell arteritis (GCA), a condition that causes inflammation in blood vessels. By comparing people with GCA to healthy volunteers, researchers hope to find clues that might help diagnose or treat the disease earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being checked for possible giant cell arteritis (GCA) or are a healthy volunteer.
- You can have a small sample of your temporal artery taken within 3 hours of joining the study.
- You do not have an active infection (like tuberculosis, HIV, or hepatitis).
- You have not taken steroids in the last week or high doses in the last month.
- You have not used other immune-suppressing drugs in the last 3 months.
- You do not have serious health conditions like cancer, diabetes, heart failure, or organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for biomarkers (biological clues) in people with newly diagnosed or flaring giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). Participating may help researchers find better ways to diagnose and monitor these conditions.
This trial looks at how the bacteria in your gut might affect giant cell arteritis, a condition that causes inflammation in blood vessels. It aims to help doctors better understand the disease.
This trial tests how well a special MRI (picture scan) can evaluate giant cell arteritis when it’s newly suspected and symptoms started recently. It may help doctors confirm the diagnosis and decide on treatment sooner by comparing MRI findings with standard testing like biopsy or ultrasound.
This study checks whether different MRI scanning details can better help doctors diagnose giant cell arteritis. If you’re being sent for an injected MRI because GCA is suspected, your scan results may help improve how future diagnoses are made.
This Phase 3 trial tests abatacept to treat giant cell arteritis (GCA), a blood vessel inflammation that can cause headaches and vision risk. It’s for people with newly diagnosed or returning (relapsing) GCA with active symptoms in the last 8 weeks.
This study looks at immune system and genetic (inherited) differences in people diagnosed with giant cell arteritis or polymyalgia rheumatica. It aims to improve understanding of why these conditions happen and how they vary between people.
Hear when a new Giant Cell Arteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.